The treatment and management of arthritis, especially osteoarthritis, has witnessed exciting development in the last 20 years since the discovery of the potentials of glucosamine. Glucosamine was first isolated in 1878 from chitin, the main component of exoskeletons (shells) and connective tissues of animals. In the 1950s, it was observed that glucosamine could stimulate increase production of proteoglycans and collagen when added to cultures of cartilage cells. In 1969, German physicians began to use an injectable form of glucosamine to treat osteoarthritis. Many scientific researches published in the last 10 years have provided evidences that glucosamine can relieve the pain and stops or slow the progression of osteoarthritis. And most excitedly is that glucosamine is very safe, with little or no side effects.
Though not conclusive, scientific research has provided enough evidences to convince medical physicians and veterinarians throughout Europe and the United States to now use glocosamine as the first-line of treatment for arthritis.
URAH Transdermal Glucosamine CreamUrah Transdermal Glucosamine Cream is currently the most scientifically advanced Transdermal Glucosamine formulation in the market, with the capability to deliver Optimal benefits with lowest side effects. Our expertise in Bio-safe formulations has enabled us to produce high-end products to meet specific needs such as individual sensitivities, gender and medical diagnosis.
- Fast & effective delivery of glucosamine to point of need
- Optimal concentration of glucosamine
- Quick and lasting relief
- Zero side effect
We produce tailor formulations fortified with other drugs or pro-drugs such as methylsulfonylmethane, Omega-3 essential fatty acids, chondroitin, vitamin C and natural extracts to enhance activity and to meet specific needs.